Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report) shares were down 10.4% on Tuesday . The company traded as low as $28.49 and last traded at $28.49. Approximately 200 shares traded hands during trading, a decline of 92% from the average daily volume of 2,432 shares. The stock had previously closed at $31.78.
Bone Biologics Stock Performance
The stock has a 50 day moving average price of $49.35 and a two-hundred day moving average price of $48.45.
Bone Biologics Company Profile
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- The 3 Best Fintech Stocks to Buy Now
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Short Selling: How to Short a Stock
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Invest in Blue Chip Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
